Merck Seeks Alternatives, Stock Plunges
22060
PHOENIX - Pharmacists stopped dispensing Vioxx and patients began asking their doctors about alternatives to the popular anti-pain drug after Merck & Co. pulled it from the market because new data found it doubled the risk of heart attacks and strokes...
769773
TRENTON, N.J. -- Shares of drug maker Merck &amp; Co. dropped 2.5 percent in heavy trading yesterday, a day after medical journal reports offered fresh ammunition to patients suing over its withdrawn painkiller Vioxx.
168349
Shares of Merck and Co. plunged almost nine per cent Monday after a media report said that documents show the pharmaceutical giant hid or denied evidence for years that its blockbuster
569961
By Rosie Murray-West, City Correspondent (Filed: 01/10/2004). US pharmaceutical giant Merck lost about a quarter of its value yesterday after it pulled arthritis drug Vioxx owing to concerns over heart attacks as a side-effect.
539996
U.S. stocks ended lower on Friday,  dragged down by a sharp fall in drugmaker Merck & Co. Inc.  MRK.N on concerns about a key drug, worries ahead of the Iraq  election and weaker-than-expected economic growth.
462652
Merck & Co. Inc., reeling from the  recent withdrawal of its Vioxx arthritis drug, on Wednesday  said 2005 earnings will decline to levels below Wall Street  expectations, the third straight year of lower results.
530890
U.S. blue chips were lower on Thursday  after drug company and Dow component Merck & Co.MRK.N said it  was withdrawing a key drug, casting a dark mood over the market  as oil prices remained above $49 a barrel.
679017
A week after saying it was withdrawing its $2.5 billion arthritis drug Vioxx from the market and losing a quarter of its stock market value as a result, Merck &amp; Co. will try to dodge the storm clouds and turn its attention tomorrow to a brighter subject with the official opening of its Boston research lab.
74666
Drug maker Merck & Co. Inc. MRK.N  dominated trading in U.S. stocks on Thursday, single-handedly  driving the 30-stock Dow Jones average lower after it withdrew  its arthritis drug Vioxx because a study showed it doubled the  risk of heart attack and stroke.
195535
Merck & Co. MRK.N and two other U.S.  drugmakers posted weak third-quarter results on Thursday, hurt  by intensifying competition and the loss of sales from drugs  found to be potentially dangerous.
63892
NEW YORK - Investors sent stocks mostly lower Thursday after Merck & Co. said it would be forced to remove one of its best-selling arthritis drugs from the market due to serious health risks...
172863
US stocks futures tumbled on Thursday after drug company Merck &amp; Co. (MRK.N: Quote, Profile, Research) announced it was recalling a key drug, indicating the market would open lower.
310914
NEW YORK, December 8  - Merck &amp; Co (MRK.NYS) has guided to lower-than-expected 2005 earnings due to the withdrawal of its blockbuster arthritis drug, Vioxx, and increased generic competition for its cholesterol drug, Zocor.
291603
NEW YORK - Investors sent stocks lower Thursday after Merck & Co. said it would be forced to remove its best-selling Vioxx arthritis drug from the market due to serious health risks...
467183
NEW YORK - Investors sent stocks mostly lower Thursday after Merck & Co. said it would be forced to remove its best-selling Vioxx arthritis drug from the market due to serious health risks...
646011
Drugmaker Merck &amp; Co., under financial siege since pulling its top painkiller Vioxx off the market in September, said Monday it has adopted a plan that
732193
* The world&#39;s biggest drug company loses $25 billion in market value in one day as investors fear another Vioxx debacle. NEW YORK - Pfizer Inc.